Literature DB >> 23166106

Endothelial cells (ECs) for vascular tissue engineering: venous ECs are less thrombogenic than arterial ECs.

I L A Geenen1, D G M Molin, N M S van den Akker, F Jeukens, H M Spronk, G W H Schurink, M J Post.   

Abstract

Primary endothelial cells (ECs) are the preferred cellular source for luminal seeding of tissue-engineered (TE) vascular grafts. Research into the potential of ECs for vascular TE has focused particularly on venous rather than arterial ECs. In this study we evaluated the functional characteristics of arterial and venous ECs, relevant for vascular TE. Porcine ECs were isolated from femoral artery (PFAECs) and vein (PFVECs). The proliferation rate was comparable for both EC sources, whereas migration, determined through a wound-healing assay, was less profound for PFVECs. EC adhesion was lower for PFVECs on collagen I, measured after 10 min of arterial shear stress. Gene expression was analysed by qRT-PCR for ECs cultured under static conditions and after exposure to arterial shear stress and revealed differences in gene expression, with lower expression of EphrinB2 and VCAM-1 and higher levels of vWF and COUP-TFII in PFVECs than in PFAECs. PFVECs exhibited diminished platelet adhesion under flow and cell-based thrombin generation was delayed for PFVECs, indicating diminished tissue factor (TF) activity. After stimulation, prostacyclin secretion, but not nitric oxide (NO), was lower in PFVECs. Our data support the use of venous ECs for TE because of their beneficial antithrombogenic profile.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  arterial-venous differences; cell culture; cell source; endothelial cells; thrombogenicity; vascular tissue engineering

Mesh:

Substances:

Year:  2012        PMID: 23166106     DOI: 10.1002/term.1642

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  9 in total

1.  Nitric Oxide Release for Improving Performance of Implantable Chemical Sensors - A Review.

Authors:  Kyoung Ha Cha; Xuewei Wang; Mark E Meyerhoff
Journal:  Appl Mater Today       Date:  2017-11-09

2.  Microfibrous Scaffolds Enhance Endothelial Differentiation and Organization of Induced Pluripotent Stem Cells.

Authors:  Joseph J Kim; Luqia Hou; Guang Yang; Nicholas P Mezak; Maureen Wanjare; Lydia M Joubert; Ngan F Huang
Journal:  Cell Mol Bioeng       Date:  2017-08-15       Impact factor: 2.321

Review 3.  Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).

Authors:  Yaqi Wo; Elizabeth J Brisbois; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biomater Sci       Date:  2016-05-26       Impact factor: 6.843

Review 4.  Arterial Venous Differentiation for Vascular Bioengineering.

Authors:  Laura Niklason; Guohao Dai
Journal:  Annu Rev Biomed Eng       Date:  2018-04-11       Impact factor: 11.324

5.  Adipose-derived endothelial and mesenchymal stem cells enhance vascular network formation on three-dimensional constructs in vitro.

Authors:  Alina Freiman; Yulia Shandalov; Dekel Rozenfeld; Erez Shor; Sofia Segal; Dror Ben-David; Shai Meretzki; Dana Egozi; Shulamit Levenberg
Journal:  Stem Cell Res Ther       Date:  2016-01-11       Impact factor: 6.832

Review 6.  Selection of different endothelialization modes and different seed cells for tissue-engineered vascular graft.

Authors:  Qingjin Cai; Wanshan Liao; Fangchao Xue; Xiaochen Wang; Weiming Zhou; Yanzhao Li; Wen Zeng
Journal:  Bioact Mater       Date:  2021-02-06

7.  Venous and Arterial Endothelial Cells from Human Umbilical Cords: Potential Cell Sources for Cardiovascular Research.

Authors:  Skadi Lau; Manfred Gossen; Andreas Lendlein; Friedrich Jung
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

8.  Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC.

Authors:  Hemang Patel; Juan Chen; Kumuda C Das; Mahendra Kavdia
Journal:  Cardiovasc Diabetol       Date:  2013-10-05       Impact factor: 9.951

Review 9.  COUP-TFII in Health and Disease.

Authors:  Simone Polvani; Sara Pepe; Stefano Milani; Andrea Galli
Journal:  Cells       Date:  2019-12-31       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.